Literature DB >> 8670259

P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture.

Y Miyagi1, S Kobayashi, A Ahmed, J Nishimura, M Fukui, H Kanaide.   

Abstract

The regulation of the cell cycle by extracellular UTP was investigated in rat aortic smooth muscle cells in primary culture (VSMCs) by means of an immunocytochemical analysis of cell cycle-specific nuclear antigens. UTP induced a rise in the cytosolic Ca2+ concentration ([Ca2+]i) of VSMCs, which was desensitized by pretreatment with ATP, but not with 2-methylthioATP nor alpha, beta-methyleneATP. The incubation of serum-deprived G0 cells with platelet derived growth factor (PDGF) induced cell cycle progression into the G1 phase without any further progression into the S and M phases, while none of the nucleotides had any effect on the cell cycle of the G0 cells. The incubation of the PDGF-pretreated cells at the G1 phase with 2-methylthioATP or alpha, beta-methyleneATP had no effect on the cell cycle of G1 cells, while the incubation of the G1 cells with UTP, ATP, and ATP gamma S stimulated cell cycle progression into the S and M phases. These results thus indicate that P2U purinergic activation mediates a [Ca2+]i transient and a progression growth factor effect of nucleotides in VSMCs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670259     DOI: 10.1006/bbrc.1996.0750

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.

Authors:  P Claes; B Grobben; K Van Kolen; D Roymans; H Slegers
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 2.  Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes.

Authors:  Gary A Weisman; M Wang; Q Kong; N E Chorna; J T Neary; Grace Y Sun; Fernando A González; C I Seye; L Erb
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 3.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925.

Authors:  Muhammad Rafehi; Joachim C Burbiel; Isaac Y Attah; Aliaa Abdelrahman; Christa E Müller
Journal:  Purinergic Signal       Date:  2016-10-20       Impact factor: 3.765

6.  Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor.

Authors:  Goro Hiroishi; Toshinori Murata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

7.  Purinergic receptor-mediated Ca signaling in the olfactory bulb and the neurogenic area of the lateral ventricles.

Authors:  Thomas Hassenklöver; Philipp Schulz; Anna Peters; Peter Schwartz; Detlev Schild; Ivan Manzini
Journal:  Purinergic Signal       Date:  2010-12-01       Impact factor: 3.765

8.  P2 receptors in cardiovascular regulation and disease.

Authors:  David Erlinge; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2007-09-21       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.